Table 5.
Global QL | |||
---|---|---|---|
Coeff | 95 % CI | p-value | |
Intercept | 29.90 | (10.71; 49.09) | 0.002 |
Baseline global QL | 0.38 | (0.28; 0.48) | <0.001 |
HADS Anxiety at baseline | 0.08 | (−0.42, 0.58) | 0.75 |
HADS Depression at baseline | −1.19 | (−1.81; −0.59) | <0.001 |
SOC at baseline | 0.13 | (−0.04; 0.30) | 0.13 |
Self-rated health, currently at baseline | |||
(very) good | Reference | ||
fair | −3.13 | (−7.28; 1.03) | 0.14 |
(very) poor | −9.28 | (−14.25; −4.32) | <0.001 |
Age | 0.21 | (0.04; 0.38) | 0.02 |
Co-morbidity | |||
0 | Reference | ||
1 | −5.14 | (−8.63; −1.66) | 0.004 |
≥2 | −6.28 | (−10.56; −2.01) | 0.004 |
Occupation | |||
Employed | Reference | ||
Unemployed | −8.32 | (−16.16; −0.49) | 0.04 |
Retired/disability/early retirement | −3.97 | (−8.14; 0.19) | 0.06 |
Non-significant predictors including gender, time of follow-up completion, SRH compared to 3 months ago at baseline, cancer diagnosis (yes/no), marital status, education, previous cancer in patient and hospital were excluded from the table. R 2 = 0.48
Significant results are highligthed in bold